WallStreetZenWallStreetZen

NASDAQ: ELEV
Elevation Oncology Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ELEV earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$45.7M
Current Profit Margin
0%

ELEV Return on Equity

Current Company
-81.9%
Current Industry
-63.5%
Current Market
188%
ELEV's Return on Equity (-81.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ELEV announces earnings.

ELEV Return on Assets

Current Company
-48.6%
Current Industry
2.9%
ELEV is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ELEV Return on Capital Employed

Current Company
-53.77%
Current Industry
19.5%
ELEV's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ELEV vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ELEV$0.00-$45.64M-$45.70MN/AN/A
ATOS$0.00-$30.07M-$30.09MN/AN/A
CRDF$488.00k-$41.04M-$41.47M+5.22%N/A
ABOS$0.00-$51.61M-$52.37MN/AN/A
INMB$155.00k-$30.01M-$30.01M+235.68%N/A
View Top Biotech Stocks

ELEV earnings dates

Next earnings date
May 2, 2024

Elevation Oncology Earnings & Revenue FAQ

What were ELEV's earnings last quarter?

On Invalid Date, Elevation Oncology (NASDAQ: ELEV) reported Q4 2023 earnings per share (EPS) of -$0.13, up 84.15% year over year. Total Elevation Oncology earnings for the quarter were -$7.90 million. In the same quarter last year, Elevation Oncology's earnings per share (EPS) was -$0.82.

If you're new to stock investing, here's how to buy Elevation Oncology stock.

What was ELEV's earnings growth in the past year?

As of Q2 2024, Elevation Oncology's earnings has grown year over year. Elevation Oncology's earnings in the past year totalled -$45.70 million.

What is ELEV's earnings date?

Elevation Oncology's earnings date is Invalid Date. Add ELEV to your watchlist to be reminded of ELEV's next earnings announcement.

What was ELEV's revenue last quarter?

On Invalid Date, Elevation Oncology (NASDAQ: ELEV) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Elevation Oncology's revenue was $0.00.

What was ELEV's revenue growth in the past year?

As of Q2 2024, Elevation Oncology's revenue has grown null year over year. Elevation Oncology's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.